Matchday Champions, a New Class of Mobile Football Game Now Available Worldwide; Kicks off With In-Game Event Hosted by Soccer Superstar Alexia Putellas and Mega Influencer Celine Dept
20.9.2024 13:00:00 CEST | Business Wire | Press release
First-of-its-Kind Free-to-Play, Card-Based, AI-Powered Soccer Simulation Game is Backed by Lionel Messi’s Play Time, Officially Licensed by FIFA and FIFPRO
Matchday, the developer of innovative mobile games for football’s five billion fans, has debuted its newest title, Matchday Champions. Today, the game is in early access globally, and it is celebrating with the limited-time “Copa Alexia x Céline,” a one-of-a-kind in-game tournament hosted by Spanish football World Cup Champion Alexia Putellas, and the immensely popular Belgian influencer Celine Dept.
Backed by Lionel Messi’s Play Time fund, Alexia Putellas, and other industry legends in sports and games, Matchday Champions is a one-of-its-kind experience. The game allows players to collect, craft and manage their own dream squad made up of both men's and women's players. It delivers the excitement of football using a cutting edge narrative creation engine, ensuring no two matches are ever the same. More than two million people have already pre-registered ahead of launch. Matchday Champions is now available in early access globally for iOS and Android phones.
Players who download the game can sign up to participate in the Copa Alexia x Céline, beginning on September 20. Hosted by World Cup champion, two-time Ballon d’Or winner and UEFA Women's Player of the Year Alexia Putellas and influencer Celine Dept, a football mega-fan with more than 50 million followers on YouTube, TikTok and Instagram, Copa Alexia x Céline challenges players to join Team Alexia or Team Celine, squaring off in a virtual tournament for bragging rights and prizes.
“Matchday is elevating two things I am very passionate about: women’s football and inclusivity,” said Putellas. “Women’s football has been on the rise for the last decade and Matchday’s co-gender football squads represent this reality in a fun and novel way for fans. I am honored to be a part of and shape a (virtual) football world that gives men and women truly equal footing. I hope the sort of representation we see in Matchday’s games will inspire the women’s football stars and all football fans of tomorrow, and help to drive forward conversations around equality.”
Licensed by FIFA and FIFPRO, Matchday offers fans the ability to collect digital player cards from tens of thousands of soccer athletes, and to combine both men’s and women’s players into their ideal squad to go head-to-head with other players’ teams. Players begin by assembling their squad, which they can start upgrading immediately. They then send their starting 11 onto the pitch, and Matchday Champions' proprietary simulation engine renders exciting in-game narratives. Play against rivals and friends while earning resources and recruiting footballers to improve their squad. Matchday Champions authentically captures the euphoria and heartbreak of real life football, and every match unfolds in a unique way.
“Football is an emotional experience for its five billion fans worldwide, and now they will be able to experience the drama of the sport in a video game that can seamlessly simulate games based on real players, real stats, and more,” said Sebastien de Halleux, Matchday co-founder and chief gaming officer. “Few players have experienced the emotional highs of football like Alexia Putellas, winning a World Cup, three UEFA Women's Champion Leagues, and 21 domestic trophies, along with all of her incredible individual accolades, so we’re honored that she has joined us not only as a Matchday ambassador but as the host of our first global in-game tournament.”
In Matchday Champions, players build and strengthen their squad, competing against others to move up through divisions and grow their club, competing with friends and Matchday’s vibrant global community, already numbering in the millions. Custom squads can be set up with ease through Matchday Champions' intuitive and accessible interface, allowing players to experiment with their team formation, as well as buy, sell and share cards with friends. Players hone their team in single player mode, then step on the pitch for a friendly match or an epic league competition with fans from all over the world. They can also join fans on the official Discord in discussing everything football, participate in weekly contests, participate in AMAs with football celebrities and follow real-world football matches.
Matchday continues to push the boundaries of digital ownership with Matchday Champions, which is part of a new category of sports games wherein fans build virtual squads by collecting digital cards of their favorite footballers. Players have true ownership of their cards and other digital items within Matchday Champions as they collect, trade and grow their dream team. These officially licensed cards can be utilized in all games within the Matchday ecosystem as it continues to grow.
Matchday previously launched the trivia and match prediction game Matchday Challenge: FIFA Women’s World Cup AU∙NZ∙2023™ Edition, which ran during FIFA Women’s World Cup and was played by millions of players all over the world.
Players can download Matchday Champions for free on the App Store or Google Play.
To learn more, please visit matchday.com, and join Matchday on X and Discord for the latest updates.
About Matchday
Matchday builds games for 5 billion football fans featuring officially licensed players and tournaments, in partnership with FIFA and FIFPRO. The company was founded by technology and gaming veterans who have successfully started and sold companies including Playfish (acq. EA), Glu Mobile (IPO), Hoodline (acq. Nextdoor), Spin (acq. Ford), and Viki (acq. Rakuten). Matchday is incubated by Leo Messi’s Play Time and backed by leading investors, with teams in San Francisco and Barcelona.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240920697449/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Datavault AI Announces Board of Directors Has Requested Management’s Complete Plan for Dividend Spin-Out of Acoustic Sciences Division into Stand-Alone Public Company7.5.2026 15:07:00 CEST | Press release
Initial planning calls for Data Sciences Division to focus efforts in cyber secure infrastructure with dedication in fintech and patented Information Data Exchange® (IDE®) Management will harness its API Media acquisition, robust patent portfolio, ADIO® Inaudible Tones, WiSA® and Dolby® partnerships to establish worldwide acoustic industry standards in high-definition wireless transmission, spatial-audio control and interoperability Plan includes API media’s stand-alone and renewed execution of WiSA semiconductor and software modules strategy with an R&D effort targeted to new robotic and drone applications Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ:DVLT), a pioneering technology licensing company seeking to redefine data valuation, monetization, and secure Web 3.0 experiences, today announced that Company management has commenced its evaluation of a potential dividend spin-out of the Company’s Acoustic Sciences division which includes its ADIO®, WiSA®, Event Citadel™,
Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis7.5.2026 14:50:00 CEST | Press release
First presentation of Week 24 results from TRuE-AD4 study in adults with moderate atopic dermatitis (AD) who had an inadequate response, intolerance or contraindication to topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs)at the 2026 EADV SymposiumThe vast majority of patients achieving EASI50 at Week 8 and continuing double-blind, as needed treatment with Opzelura® (ruxolitinib) cream through Week 24 demonstrated disease control, with 84.3% achieving EASI75 (a ≥75% improvement in the Eczema Area and Severity Index score from baseline) and 70.6% achieving IGA-TS (Investigator’s Global Assessment Treatment Success)Data support Type-II variation application submitted for ruxolitinib cream 1.5% for the treatment of adults with moderate AD in the European Union (EU), feedback expected in 1H 2026 Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib) cream in adults with mode
Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release
Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L
2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release
“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release
Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom